Established a quality research system for antibodies and ADC drugs, especially the application of LC-MS technology in the analyses of the molecular weight, peptide mapping, glycosylation profile, and other quality attributes of the antibodies, as well as in the analyses of ADC drug-antibody ratio (DAR), drug conjugation site, and ADC metabolites, etc.
